Global Nivolumab Market Growth 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
LPI (LP Information)' newest research report, the “Nivolumab Industry Forecast” looks at past sales and reviews total world Nivolumab sales in 2022, providing a comprehensive analysis by region and market sector of projected Nivolumab sales for 2023 through 2029. With Nivolumab sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Nivolumab industry.
This Insight Report provides a comprehensive analysis of the global Nivolumab landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Nivolumab portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Nivolumab market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Nivolumab and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Nivolumab.
The global Nivolumab market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Nivolumab is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Nivolumab is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Nivolumab is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Nivolumab players cover Ono Pharmaceutical and Bristol-Myers Squibb etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Nivolumab market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
What is the 10-year outlook for the global Nivolumab market?
What factors are driving Nivolumab market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Nivolumab market opportunities vary by end market size?
How does Nivolumab break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
LPI (LP Information)' newest research report, the “Nivolumab Industry Forecast” looks at past sales and reviews total world Nivolumab sales in 2022, providing a comprehensive analysis by region and market sector of projected Nivolumab sales for 2023 through 2029. With Nivolumab sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Nivolumab industry.
This Insight Report provides a comprehensive analysis of the global Nivolumab landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Nivolumab portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Nivolumab market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Nivolumab and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Nivolumab.
The global Nivolumab market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Nivolumab is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Nivolumab is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Nivolumab is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Nivolumab players cover Ono Pharmaceutical and Bristol-Myers Squibb etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Nivolumab market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
- Injection 4mL
- Injection 10mL
- Unresectable Melanoma
- Metastatic Melanoma
- Metastatic Squamous NSCLC
- Classical Hodgkin Lymphoma
- Renal Cell Carcinoma
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Ono Pharmaceutical
- Bristol-Myers Squibb
What is the 10-year outlook for the global Nivolumab market?
What factors are driving Nivolumab market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Nivolumab market opportunities vary by end market size?
How does Nivolumab break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Nivolumab Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Nivolumab by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Nivolumab by Country/Region, 2018, 2022 & 2029
2.2 Nivolumab Segment by Type
2.2.1 Injection 4mL
2.2.2 Injection 10mL
2.3 Nivolumab Sales by Type
2.3.1 Global Nivolumab Sales Market Share by Type (2018-2023)
2.3.2 Global Nivolumab Revenue and Market Share by Type (2018-2023)
2.3.3 Global Nivolumab Sale Price by Type (2018-2023)
2.4 Nivolumab Segment by Application
2.4.1 Unresectable Melanoma
2.4.2 Metastatic Melanoma
2.4.3 Metastatic Squamous NSCLC
2.4.4 Classical Hodgkin Lymphoma
2.4.5 Renal Cell Carcinoma
2.4.6 Other
2.5 Nivolumab Sales by Application
2.5.1 Global Nivolumab Sale Market Share by Application (2018-2023)
2.5.2 Global Nivolumab Revenue and Market Share by Application (2018-2023)
2.5.3 Global Nivolumab Sale Price by Application (2018-2023)
3 GLOBAL NIVOLUMAB BY COMPANY
3.1 Global Nivolumab Breakdown Data by Company
3.1.1 Global Nivolumab Annual Sales by Company (2018-2023)
3.1.2 Global Nivolumab Sales Market Share by Company (2018-2023)
3.2 Global Nivolumab Annual Revenue by Company (2018-2023)
3.2.1 Global Nivolumab Revenue by Company (2018-2023)
3.2.2 Global Nivolumab Revenue Market Share by Company (2018-2023)
3.3 Global Nivolumab Sale Price by Company
3.4 Key Manufacturers Nivolumab Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Nivolumab Product Location Distribution
3.4.2 Players Nivolumab Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR NIVOLUMAB BY GEOGRAPHIC REGION
4.1 World Historic Nivolumab Market Size by Geographic Region (2018-2023)
4.1.1 Global Nivolumab Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Nivolumab Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Nivolumab Market Size by Country/Region (2018-2023)
4.2.1 Global Nivolumab Annual Sales by Country/Region (2018-2023)
4.2.2 Global Nivolumab Annual Revenue by Country/Region (2018-2023)
4.3 Americas Nivolumab Sales Growth
4.4 APAC Nivolumab Sales Growth
4.5 Europe Nivolumab Sales Growth
4.6 Middle East & Africa Nivolumab Sales Growth
5 AMERICAS
5.1 Americas Nivolumab Sales by Country
5.1.1 Americas Nivolumab Sales by Country (2018-2023)
5.1.2 Americas Nivolumab Revenue by Country (2018-2023)
5.2 Americas Nivolumab Sales by Type
5.3 Americas Nivolumab Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Nivolumab Sales by Region
6.1.1 APAC Nivolumab Sales by Region (2018-2023)
6.1.2 APAC Nivolumab Revenue by Region (2018-2023)
6.2 APAC Nivolumab Sales by Type
6.3 APAC Nivolumab Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Nivolumab by Country
7.1.1 Europe Nivolumab Sales by Country (2018-2023)
7.1.2 Europe Nivolumab Revenue by Country (2018-2023)
7.2 Europe Nivolumab Sales by Type
7.3 Europe Nivolumab Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Nivolumab by Country
8.1.1 Middle East & Africa Nivolumab Sales by Country (2018-2023)
8.1.2 Middle East & Africa Nivolumab Revenue by Country (2018-2023)
8.2 Middle East & Africa Nivolumab Sales by Type
8.3 Middle East & Africa Nivolumab Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Nivolumab
10.3 Manufacturing Process Analysis of Nivolumab
10.4 Industry Chain Structure of Nivolumab
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Nivolumab Distributors
11.3 Nivolumab Customer
12 WORLD FORECAST REVIEW FOR NIVOLUMAB BY GEOGRAPHIC REGION
12.1 Global Nivolumab Market Size Forecast by Region
12.1.1 Global Nivolumab Forecast by Region (2024-2029)
12.1.2 Global Nivolumab Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Nivolumab Forecast by Type
12.7 Global Nivolumab Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Ono Pharmaceutical
13.1.1 Ono Pharmaceutical Company Information
13.1.2 Ono Pharmaceutical Nivolumab Product Portfolios and Specifications
13.1.3 Ono Pharmaceutical Nivolumab Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Ono Pharmaceutical Main Business Overview
13.1.5 Ono Pharmaceutical Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Nivolumab Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Nivolumab by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Nivolumab by Country/Region, 2018, 2022 & 2029
2.2 Nivolumab Segment by Type
2.2.1 Injection 4mL
2.2.2 Injection 10mL
2.3 Nivolumab Sales by Type
2.3.1 Global Nivolumab Sales Market Share by Type (2018-2023)
2.3.2 Global Nivolumab Revenue and Market Share by Type (2018-2023)
2.3.3 Global Nivolumab Sale Price by Type (2018-2023)
2.4 Nivolumab Segment by Application
2.4.1 Unresectable Melanoma
2.4.2 Metastatic Melanoma
2.4.3 Metastatic Squamous NSCLC
2.4.4 Classical Hodgkin Lymphoma
2.4.5 Renal Cell Carcinoma
2.4.6 Other
2.5 Nivolumab Sales by Application
2.5.1 Global Nivolumab Sale Market Share by Application (2018-2023)
2.5.2 Global Nivolumab Revenue and Market Share by Application (2018-2023)
2.5.3 Global Nivolumab Sale Price by Application (2018-2023)
3 GLOBAL NIVOLUMAB BY COMPANY
3.1 Global Nivolumab Breakdown Data by Company
3.1.1 Global Nivolumab Annual Sales by Company (2018-2023)
3.1.2 Global Nivolumab Sales Market Share by Company (2018-2023)
3.2 Global Nivolumab Annual Revenue by Company (2018-2023)
3.2.1 Global Nivolumab Revenue by Company (2018-2023)
3.2.2 Global Nivolumab Revenue Market Share by Company (2018-2023)
3.3 Global Nivolumab Sale Price by Company
3.4 Key Manufacturers Nivolumab Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Nivolumab Product Location Distribution
3.4.2 Players Nivolumab Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR NIVOLUMAB BY GEOGRAPHIC REGION
4.1 World Historic Nivolumab Market Size by Geographic Region (2018-2023)
4.1.1 Global Nivolumab Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Nivolumab Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Nivolumab Market Size by Country/Region (2018-2023)
4.2.1 Global Nivolumab Annual Sales by Country/Region (2018-2023)
4.2.2 Global Nivolumab Annual Revenue by Country/Region (2018-2023)
4.3 Americas Nivolumab Sales Growth
4.4 APAC Nivolumab Sales Growth
4.5 Europe Nivolumab Sales Growth
4.6 Middle East & Africa Nivolumab Sales Growth
5 AMERICAS
5.1 Americas Nivolumab Sales by Country
5.1.1 Americas Nivolumab Sales by Country (2018-2023)
5.1.2 Americas Nivolumab Revenue by Country (2018-2023)
5.2 Americas Nivolumab Sales by Type
5.3 Americas Nivolumab Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Nivolumab Sales by Region
6.1.1 APAC Nivolumab Sales by Region (2018-2023)
6.1.2 APAC Nivolumab Revenue by Region (2018-2023)
6.2 APAC Nivolumab Sales by Type
6.3 APAC Nivolumab Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Nivolumab by Country
7.1.1 Europe Nivolumab Sales by Country (2018-2023)
7.1.2 Europe Nivolumab Revenue by Country (2018-2023)
7.2 Europe Nivolumab Sales by Type
7.3 Europe Nivolumab Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Nivolumab by Country
8.1.1 Middle East & Africa Nivolumab Sales by Country (2018-2023)
8.1.2 Middle East & Africa Nivolumab Revenue by Country (2018-2023)
8.2 Middle East & Africa Nivolumab Sales by Type
8.3 Middle East & Africa Nivolumab Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Nivolumab
10.3 Manufacturing Process Analysis of Nivolumab
10.4 Industry Chain Structure of Nivolumab
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Nivolumab Distributors
11.3 Nivolumab Customer
12 WORLD FORECAST REVIEW FOR NIVOLUMAB BY GEOGRAPHIC REGION
12.1 Global Nivolumab Market Size Forecast by Region
12.1.1 Global Nivolumab Forecast by Region (2024-2029)
12.1.2 Global Nivolumab Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Nivolumab Forecast by Type
12.7 Global Nivolumab Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Ono Pharmaceutical
13.1.1 Ono Pharmaceutical Company Information
13.1.2 Ono Pharmaceutical Nivolumab Product Portfolios and Specifications
13.1.3 Ono Pharmaceutical Nivolumab Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Ono Pharmaceutical Main Business Overview
13.1.5 Ono Pharmaceutical Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Nivolumab Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Nivolumab Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Injection 4mL
Table 4. Major Players of Injection 10mL
Table 5. Global Nivolumab Sales by Type (2018-2023) & (K Pcs)
Table 6. Global Nivolumab Sales Market Share by Type (2018-2023)
Table 7. Global Nivolumab Revenue by Type (2018-2023) & ($ million)
Table 8. Global Nivolumab Revenue Market Share by Type (2018-2023)
Table 9. Global Nivolumab Sale Price by Type (2018-2023) & (USD/Pcs)
Table 10. Global Nivolumab Sales by Application (2018-2023) & (K Pcs)
Table 11. Global Nivolumab Sales Market Share by Application (2018-2023)
Table 12. Global Nivolumab Revenue by Application (2018-2023)
Table 13. Global Nivolumab Revenue Market Share by Application (2018-2023)
Table 14. Global Nivolumab Sale Price by Application (2018-2023) & (USD/Pcs)
Table 15. Global Nivolumab Sales by Company (2018-2023) & (K Pcs)
Table 16. Global Nivolumab Sales Market Share by Company (2018-2023)
Table 17. Global Nivolumab Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Nivolumab Revenue Market Share by Company (2018-2023)
Table 19. Global Nivolumab Sale Price by Company (2018-2023) & (USD/Pcs)
Table 20. Key Manufacturers Nivolumab Producing Area Distribution and Sales Area
Table 21. Players Nivolumab Products Offered
Table 22. Nivolumab Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Nivolumab Sales by Geographic Region (2018-2023) & (K Pcs)
Table 26. Global Nivolumab Sales Market Share Geographic Region (2018-2023)
Table 27. Global Nivolumab Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Nivolumab Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Nivolumab Sales by Country/Region (2018-2023) & (K Pcs)
Table 30. Global Nivolumab Sales Market Share by Country/Region (2018-2023)
Table 31. Global Nivolumab Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Nivolumab Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Nivolumab Sales by Country (2018-2023) & (K Pcs)
Table 34. Americas Nivolumab Sales Market Share by Country (2018-2023)
Table 35. Americas Nivolumab Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Nivolumab Revenue Market Share by Country (2018-2023)
Table 37. Americas Nivolumab Sales by Type (2018-2023) & (K Pcs)
Table 38. Americas Nivolumab Sales by Application (2018-2023) & (K Pcs)
Table 39. APAC Nivolumab Sales by Region (2018-2023) & (K Pcs)
Table 40. APAC Nivolumab Sales Market Share by Region (2018-2023)
Table 41. APAC Nivolumab Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Nivolumab Revenue Market Share by Region (2018-2023)
Table 43. APAC Nivolumab Sales by Type (2018-2023) & (K Pcs)
Table 44. APAC Nivolumab Sales by Application (2018-2023) & (K Pcs)
Table 45. Europe Nivolumab Sales by Country (2018-2023) & (K Pcs)
Table 46. Europe Nivolumab Sales Market Share by Country (2018-2023)
Table 47. Europe Nivolumab Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Nivolumab Revenue Market Share by Country (2018-2023)
Table 49. Europe Nivolumab Sales by Type (2018-2023) & (K Pcs)
Table 50. Europe Nivolumab Sales by Application (2018-2023) & (K Pcs)
Table 51. Middle East & Africa Nivolumab Sales by Country (2018-2023) & (K Pcs)
Table 52. Middle East & Africa Nivolumab Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Nivolumab Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Nivolumab Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Nivolumab Sales by Type (2018-2023) & (K Pcs)
Table 56. Middle East & Africa Nivolumab Sales by Application (2018-2023) & (K Pcs)
Table 57. Key Market Drivers & Growth Opportunities of Nivolumab
Table 58. Key Market Challenges & Risks of Nivolumab
Table 59. Key Industry Trends of Nivolumab
Table 60. Nivolumab Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Nivolumab Distributors List
Table 63. Nivolumab Customer List
Table 64. Global Nivolumab Sales Forecast by Region (2024-2029) & (K Pcs)
Table 65. Global Nivolumab Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Nivolumab Sales Forecast by Country (2024-2029) & (K Pcs)
Table 67. Americas Nivolumab Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Nivolumab Sales Forecast by Region (2024-2029) & (K Pcs)
Table 69. APAC Nivolumab Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Nivolumab Sales Forecast by Country (2024-2029) & (K Pcs)
Table 71. Europe Nivolumab Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Nivolumab Sales Forecast by Country (2024-2029) & (K Pcs)
Table 73. Middle East & Africa Nivolumab Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Nivolumab Sales Forecast by Type (2024-2029) & (K Pcs)
Table 75. Global Nivolumab Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Nivolumab Sales Forecast by Application (2024-2029) & (K Pcs)
Table 77. Global Nivolumab Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Ono Pharmaceutical Basic Information, Nivolumab Manufacturing Base, Sales Area and Its Competitors
Table 79. Ono Pharmaceutical Nivolumab Product Portfolios and Specifications
Table 80. Ono Pharmaceutical Nivolumab Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 81. Ono Pharmaceutical Main Business
Table 82. Ono Pharmaceutical Latest Developments
Table 83. Bristol-Myers Squibb Basic Information, Nivolumab Manufacturing Base, Sales Area and Its Competitors
Table 84. Bristol-Myers Squibb Nivolumab Product Portfolios and Specifications
Table 85. Bristol-Myers Squibb Nivolumab Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 86. Bristol-Myers Squibb Main Business
Table 87. Bristol-Myers Squibb Latest Developments
Table 1. Nivolumab Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Nivolumab Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Injection 4mL
Table 4. Major Players of Injection 10mL
Table 5. Global Nivolumab Sales by Type (2018-2023) & (K Pcs)
Table 6. Global Nivolumab Sales Market Share by Type (2018-2023)
Table 7. Global Nivolumab Revenue by Type (2018-2023) & ($ million)
Table 8. Global Nivolumab Revenue Market Share by Type (2018-2023)
Table 9. Global Nivolumab Sale Price by Type (2018-2023) & (USD/Pcs)
Table 10. Global Nivolumab Sales by Application (2018-2023) & (K Pcs)
Table 11. Global Nivolumab Sales Market Share by Application (2018-2023)
Table 12. Global Nivolumab Revenue by Application (2018-2023)
Table 13. Global Nivolumab Revenue Market Share by Application (2018-2023)
Table 14. Global Nivolumab Sale Price by Application (2018-2023) & (USD/Pcs)
Table 15. Global Nivolumab Sales by Company (2018-2023) & (K Pcs)
Table 16. Global Nivolumab Sales Market Share by Company (2018-2023)
Table 17. Global Nivolumab Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Nivolumab Revenue Market Share by Company (2018-2023)
Table 19. Global Nivolumab Sale Price by Company (2018-2023) & (USD/Pcs)
Table 20. Key Manufacturers Nivolumab Producing Area Distribution and Sales Area
Table 21. Players Nivolumab Products Offered
Table 22. Nivolumab Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Nivolumab Sales by Geographic Region (2018-2023) & (K Pcs)
Table 26. Global Nivolumab Sales Market Share Geographic Region (2018-2023)
Table 27. Global Nivolumab Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Nivolumab Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Nivolumab Sales by Country/Region (2018-2023) & (K Pcs)
Table 30. Global Nivolumab Sales Market Share by Country/Region (2018-2023)
Table 31. Global Nivolumab Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Nivolumab Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Nivolumab Sales by Country (2018-2023) & (K Pcs)
Table 34. Americas Nivolumab Sales Market Share by Country (2018-2023)
Table 35. Americas Nivolumab Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Nivolumab Revenue Market Share by Country (2018-2023)
Table 37. Americas Nivolumab Sales by Type (2018-2023) & (K Pcs)
Table 38. Americas Nivolumab Sales by Application (2018-2023) & (K Pcs)
Table 39. APAC Nivolumab Sales by Region (2018-2023) & (K Pcs)
Table 40. APAC Nivolumab Sales Market Share by Region (2018-2023)
Table 41. APAC Nivolumab Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Nivolumab Revenue Market Share by Region (2018-2023)
Table 43. APAC Nivolumab Sales by Type (2018-2023) & (K Pcs)
Table 44. APAC Nivolumab Sales by Application (2018-2023) & (K Pcs)
Table 45. Europe Nivolumab Sales by Country (2018-2023) & (K Pcs)
Table 46. Europe Nivolumab Sales Market Share by Country (2018-2023)
Table 47. Europe Nivolumab Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Nivolumab Revenue Market Share by Country (2018-2023)
Table 49. Europe Nivolumab Sales by Type (2018-2023) & (K Pcs)
Table 50. Europe Nivolumab Sales by Application (2018-2023) & (K Pcs)
Table 51. Middle East & Africa Nivolumab Sales by Country (2018-2023) & (K Pcs)
Table 52. Middle East & Africa Nivolumab Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Nivolumab Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Nivolumab Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Nivolumab Sales by Type (2018-2023) & (K Pcs)
Table 56. Middle East & Africa Nivolumab Sales by Application (2018-2023) & (K Pcs)
Table 57. Key Market Drivers & Growth Opportunities of Nivolumab
Table 58. Key Market Challenges & Risks of Nivolumab
Table 59. Key Industry Trends of Nivolumab
Table 60. Nivolumab Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Nivolumab Distributors List
Table 63. Nivolumab Customer List
Table 64. Global Nivolumab Sales Forecast by Region (2024-2029) & (K Pcs)
Table 65. Global Nivolumab Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Nivolumab Sales Forecast by Country (2024-2029) & (K Pcs)
Table 67. Americas Nivolumab Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Nivolumab Sales Forecast by Region (2024-2029) & (K Pcs)
Table 69. APAC Nivolumab Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Nivolumab Sales Forecast by Country (2024-2029) & (K Pcs)
Table 71. Europe Nivolumab Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Nivolumab Sales Forecast by Country (2024-2029) & (K Pcs)
Table 73. Middle East & Africa Nivolumab Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Nivolumab Sales Forecast by Type (2024-2029) & (K Pcs)
Table 75. Global Nivolumab Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Nivolumab Sales Forecast by Application (2024-2029) & (K Pcs)
Table 77. Global Nivolumab Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Ono Pharmaceutical Basic Information, Nivolumab Manufacturing Base, Sales Area and Its Competitors
Table 79. Ono Pharmaceutical Nivolumab Product Portfolios and Specifications
Table 80. Ono Pharmaceutical Nivolumab Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 81. Ono Pharmaceutical Main Business
Table 82. Ono Pharmaceutical Latest Developments
Table 83. Bristol-Myers Squibb Basic Information, Nivolumab Manufacturing Base, Sales Area and Its Competitors
Table 84. Bristol-Myers Squibb Nivolumab Product Portfolios and Specifications
Table 85. Bristol-Myers Squibb Nivolumab Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 86. Bristol-Myers Squibb Main Business
Table 87. Bristol-Myers Squibb Latest Developments
LIST OF FIGURES
Figure 1. Picture of Nivolumab
Figure 2. Nivolumab Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Nivolumab Sales Growth Rate 2018-2029 (K Pcs)
Figure 7. Global Nivolumab Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Nivolumab Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Injection 4mL
Figure 10. Product Picture of Injection 10mL
Figure 11. Global Nivolumab Sales Market Share by Type in 2022
Figure 12. Global Nivolumab Revenue Market Share by Type (2018-2023)
Figure 13. Nivolumab Consumed in Unresectable Melanoma
Figure 14. Global Nivolumab Market: Unresectable Melanoma (2018-2023) & (K Pcs)
Figure 15. Nivolumab Consumed in Metastatic Melanoma
Figure 16. Global Nivolumab Market: Metastatic Melanoma (2018-2023) & (K Pcs)
Figure 17. Nivolumab Consumed in Metastatic Squamous NSCLC
Figure 18. Global Nivolumab Market: Metastatic Squamous NSCLC (2018-2023) & (K Pcs)
Figure 19. Nivolumab Consumed in Classical Hodgkin Lymphoma
Figure 20. Global Nivolumab Market: Classical Hodgkin Lymphoma (2018-2023) & (K Pcs)
Figure 21. Nivolumab Consumed in Renal Cell Carcinoma
Figure 22. Global Nivolumab Market: Renal Cell Carcinoma (2018-2023) & (K Pcs)
Figure 23. Nivolumab Consumed in Other
Figure 24. Global Nivolumab Market: Other (2018-2023) & (K Pcs)
Figure 25. Global Nivolumab Sales Market Share by Application (2022)
Figure 26. Global Nivolumab Revenue Market Share by Application in 2022
Figure 27. Nivolumab Sales Market by Company in 2022 (K Pcs)
Figure 28. Global Nivolumab Sales Market Share by Company in 2022
Figure 29. Nivolumab Revenue Market by Company in 2022 ($ Million)
Figure 30. Global Nivolumab Revenue Market Share by Company in 2022
Figure 31. Global Nivolumab Sales Market Share by Geographic Region (2018-2023)
Figure 32. Global Nivolumab Revenue Market Share by Geographic Region in 2022
Figure 33. Americas Nivolumab Sales 2018-2023 (K Pcs)
Figure 34. Americas Nivolumab Revenue 2018-2023 ($ Millions)
Figure 35. APAC Nivolumab Sales 2018-2023 (K Pcs)
Figure 36. APAC Nivolumab Revenue 2018-2023 ($ Millions)
Figure 37. Europe Nivolumab Sales 2018-2023 (K Pcs)
Figure 38. Europe Nivolumab Revenue 2018-2023 ($ Millions)
Figure 39. Middle East & Africa Nivolumab Sales 2018-2023 (K Pcs)
Figure 40. Middle East & Africa Nivolumab Revenue 2018-2023 ($ Millions)
Figure 41. Americas Nivolumab Sales Market Share by Country in 2022
Figure 42. Americas Nivolumab Revenue Market Share by Country in 2022
Figure 43. Americas Nivolumab Sales Market Share by Type (2018-2023)
Figure 44. Americas Nivolumab Sales Market Share by Application (2018-2023)
Figure 45. United States Nivolumab Revenue Growth 2018-2023 ($ Millions)
Figure 46. Canada Nivolumab Revenue Growth 2018-2023 ($ Millions)
Figure 47. Mexico Nivolumab Revenue Growth 2018-2023 ($ Millions)
Figure 48. Brazil Nivolumab Revenue Growth 2018-2023 ($ Millions)
Figure 49. APAC Nivolumab Sales Market Share by Region in 2022
Figure 50. APAC Nivolumab Revenue Market Share by Regions in 2022
Figure 51. APAC Nivolumab Sales Market Share by Type (2018-2023)
Figure 52. APAC Nivolumab Sales Market Share by Application (2018-2023)
Figure 53. China Nivolumab Revenue Growth 2018-2023 ($ Millions)
Figure 54. Japan Nivolumab Revenue Growth 2018-2023 ($ Millions)
Figure 55. South Korea Nivolumab Revenue Growth 2018-2023 ($ Millions)
Figure 56. Southeast Asia Nivolumab Revenue Growth 2018-2023 ($ Millions)
Figure 57. India Nivolumab Revenue Growth 2018-2023 ($ Millions)
Figure 58. Australia Nivolumab Revenue Growth 2018-2023 ($ Millions)
Figure 59. China Taiwan Nivolumab Revenue Growth 2018-2023 ($ Millions)
Figure 60. Europe Nivolumab Sales Market Share by Country in 2022
Figure 61. Europe Nivolumab Revenue Market Share by Country in 2022
Figure 62. Europe Nivolumab Sales Market Share by Type (2018-2023)
Figure 63. Europe Nivolumab Sales Market Share by Application (2018-2023)
Figure 64. Germany Nivolumab Revenue Growth 2018-2023 ($ Millions)
Figure 65. France Nivolumab Revenue Growth 2018-2023 ($ Millions)
Figure 66. UK Nivolumab Revenue Growth 2018-2023 ($ Millions)
Figure 67. Italy Nivolumab Revenue Growth 2018-2023 ($ Millions)
Figure 68. Russia Nivolumab Revenue Growth 2018-2023 ($ Millions)
Figure 69. Middle East & Africa Nivolumab Sales Market Share by Country in 2022
Figure 70. Middle East & Africa Nivolumab Revenue Market Share by Country in 2022
Figure 71. Middle East & Africa Nivolumab Sales Market Share by Type (2018-2023)
Figure 72. Middle East & Africa Nivolumab Sales Market Share by Application (2018-2023)
Figure 73. Egypt Nivolumab Revenue Growth 2018-2023 ($ Millions)
Figure 74. South Africa Nivolumab Revenue Growth 2018-2023 ($ Millions)
Figure 75. Israel Nivolumab Revenue Growth 2018-2023 ($ Millions)
Figure 76. Turkey Nivolumab Revenue Growth 2018-2023 ($ Millions)
Figure 77. GCC Country Nivolumab Revenue Growth 2018-2023 ($ Millions)
Figure 78. Manufacturing Cost Structure Analysis of Nivolumab in 2022
Figure 79. Manufacturing Process Analysis of Nivolumab
Figure 80. Industry Chain Structure of Nivolumab
Figure 81. Channels of Distribution
Figure 82. Global Nivolumab Sales Market Forecast by Region (2024-2029)
Figure 83. Global Nivolumab Revenue Market Share Forecast by Region (2024-2029)
Figure 84. Global Nivolumab Sales Market Share Forecast by Type (2024-2029)
Figure 85. Global Nivolumab Revenue Market Share Forecast by Type (2024-2029)
Figure 86. Global Nivolumab Sales Market Share Forecast by Application (2024-2029)
Figure 87. Global Nivolumab Revenue Market Share Forecast by Application (2024-2029)
Figure 1. Picture of Nivolumab
Figure 2. Nivolumab Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Nivolumab Sales Growth Rate 2018-2029 (K Pcs)
Figure 7. Global Nivolumab Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Nivolumab Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Injection 4mL
Figure 10. Product Picture of Injection 10mL
Figure 11. Global Nivolumab Sales Market Share by Type in 2022
Figure 12. Global Nivolumab Revenue Market Share by Type (2018-2023)
Figure 13. Nivolumab Consumed in Unresectable Melanoma
Figure 14. Global Nivolumab Market: Unresectable Melanoma (2018-2023) & (K Pcs)
Figure 15. Nivolumab Consumed in Metastatic Melanoma
Figure 16. Global Nivolumab Market: Metastatic Melanoma (2018-2023) & (K Pcs)
Figure 17. Nivolumab Consumed in Metastatic Squamous NSCLC
Figure 18. Global Nivolumab Market: Metastatic Squamous NSCLC (2018-2023) & (K Pcs)
Figure 19. Nivolumab Consumed in Classical Hodgkin Lymphoma
Figure 20. Global Nivolumab Market: Classical Hodgkin Lymphoma (2018-2023) & (K Pcs)
Figure 21. Nivolumab Consumed in Renal Cell Carcinoma
Figure 22. Global Nivolumab Market: Renal Cell Carcinoma (2018-2023) & (K Pcs)
Figure 23. Nivolumab Consumed in Other
Figure 24. Global Nivolumab Market: Other (2018-2023) & (K Pcs)
Figure 25. Global Nivolumab Sales Market Share by Application (2022)
Figure 26. Global Nivolumab Revenue Market Share by Application in 2022
Figure 27. Nivolumab Sales Market by Company in 2022 (K Pcs)
Figure 28. Global Nivolumab Sales Market Share by Company in 2022
Figure 29. Nivolumab Revenue Market by Company in 2022 ($ Million)
Figure 30. Global Nivolumab Revenue Market Share by Company in 2022
Figure 31. Global Nivolumab Sales Market Share by Geographic Region (2018-2023)
Figure 32. Global Nivolumab Revenue Market Share by Geographic Region in 2022
Figure 33. Americas Nivolumab Sales 2018-2023 (K Pcs)
Figure 34. Americas Nivolumab Revenue 2018-2023 ($ Millions)
Figure 35. APAC Nivolumab Sales 2018-2023 (K Pcs)
Figure 36. APAC Nivolumab Revenue 2018-2023 ($ Millions)
Figure 37. Europe Nivolumab Sales 2018-2023 (K Pcs)
Figure 38. Europe Nivolumab Revenue 2018-2023 ($ Millions)
Figure 39. Middle East & Africa Nivolumab Sales 2018-2023 (K Pcs)
Figure 40. Middle East & Africa Nivolumab Revenue 2018-2023 ($ Millions)
Figure 41. Americas Nivolumab Sales Market Share by Country in 2022
Figure 42. Americas Nivolumab Revenue Market Share by Country in 2022
Figure 43. Americas Nivolumab Sales Market Share by Type (2018-2023)
Figure 44. Americas Nivolumab Sales Market Share by Application (2018-2023)
Figure 45. United States Nivolumab Revenue Growth 2018-2023 ($ Millions)
Figure 46. Canada Nivolumab Revenue Growth 2018-2023 ($ Millions)
Figure 47. Mexico Nivolumab Revenue Growth 2018-2023 ($ Millions)
Figure 48. Brazil Nivolumab Revenue Growth 2018-2023 ($ Millions)
Figure 49. APAC Nivolumab Sales Market Share by Region in 2022
Figure 50. APAC Nivolumab Revenue Market Share by Regions in 2022
Figure 51. APAC Nivolumab Sales Market Share by Type (2018-2023)
Figure 52. APAC Nivolumab Sales Market Share by Application (2018-2023)
Figure 53. China Nivolumab Revenue Growth 2018-2023 ($ Millions)
Figure 54. Japan Nivolumab Revenue Growth 2018-2023 ($ Millions)
Figure 55. South Korea Nivolumab Revenue Growth 2018-2023 ($ Millions)
Figure 56. Southeast Asia Nivolumab Revenue Growth 2018-2023 ($ Millions)
Figure 57. India Nivolumab Revenue Growth 2018-2023 ($ Millions)
Figure 58. Australia Nivolumab Revenue Growth 2018-2023 ($ Millions)
Figure 59. China Taiwan Nivolumab Revenue Growth 2018-2023 ($ Millions)
Figure 60. Europe Nivolumab Sales Market Share by Country in 2022
Figure 61. Europe Nivolumab Revenue Market Share by Country in 2022
Figure 62. Europe Nivolumab Sales Market Share by Type (2018-2023)
Figure 63. Europe Nivolumab Sales Market Share by Application (2018-2023)
Figure 64. Germany Nivolumab Revenue Growth 2018-2023 ($ Millions)
Figure 65. France Nivolumab Revenue Growth 2018-2023 ($ Millions)
Figure 66. UK Nivolumab Revenue Growth 2018-2023 ($ Millions)
Figure 67. Italy Nivolumab Revenue Growth 2018-2023 ($ Millions)
Figure 68. Russia Nivolumab Revenue Growth 2018-2023 ($ Millions)
Figure 69. Middle East & Africa Nivolumab Sales Market Share by Country in 2022
Figure 70. Middle East & Africa Nivolumab Revenue Market Share by Country in 2022
Figure 71. Middle East & Africa Nivolumab Sales Market Share by Type (2018-2023)
Figure 72. Middle East & Africa Nivolumab Sales Market Share by Application (2018-2023)
Figure 73. Egypt Nivolumab Revenue Growth 2018-2023 ($ Millions)
Figure 74. South Africa Nivolumab Revenue Growth 2018-2023 ($ Millions)
Figure 75. Israel Nivolumab Revenue Growth 2018-2023 ($ Millions)
Figure 76. Turkey Nivolumab Revenue Growth 2018-2023 ($ Millions)
Figure 77. GCC Country Nivolumab Revenue Growth 2018-2023 ($ Millions)
Figure 78. Manufacturing Cost Structure Analysis of Nivolumab in 2022
Figure 79. Manufacturing Process Analysis of Nivolumab
Figure 80. Industry Chain Structure of Nivolumab
Figure 81. Channels of Distribution
Figure 82. Global Nivolumab Sales Market Forecast by Region (2024-2029)
Figure 83. Global Nivolumab Revenue Market Share Forecast by Region (2024-2029)
Figure 84. Global Nivolumab Sales Market Share Forecast by Type (2024-2029)
Figure 85. Global Nivolumab Revenue Market Share Forecast by Type (2024-2029)
Figure 86. Global Nivolumab Sales Market Share Forecast by Application (2024-2029)
Figure 87. Global Nivolumab Revenue Market Share Forecast by Application (2024-2029)
